Michigan Heart

Ypsilanti, Michigan 48197-8633

3 studies enrolling now · 40 studies all time

What they study most

ASCVD, Atherosclerosis, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Bleeding, Bradycardia, Cardiac Resynchronization Therapy, Cardiomyopathies, Cardiovascular Disease, Chronic Heart Failure With Reduced Ejection Fraction, Class I or II Indication for Implantation of a Single Chamber Ventricular Pacemaker According to ACC/AHA/HRS 2001 Guidelines and Any National Guidelines, Congestive Heart Failure

Studies at this site

• Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias — Recruiting now
• BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT — Recruiting now
• Lead Evaluation for Defibrillation and Reliability Post Approval Study — Enrolling by invitation
• CREST-2 Long-term Observational Extension Study — Running, not enrolling
• Micra AV Transcatheter Pacing System Post-Approval Registry — Completed
• Personalized Therapy Study - Attain Stability Quad Post-Approval Study — Running, not enrolling
• PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease — Completed
• Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry) — Running, not enrolling
• Personalized Therapy Study - HFRS (TriageHF) Post Approval Study — Running, not enrolling
• Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) — Running, not enrolling
• PRE-DETERMINE Cohort Study — Running, not enrolling
• Enlighten Study: The EV-ICD Post Approval Registry — Running, not enrolling
• The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker — Completed
• Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy — Completed
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling
• AdaptResponse Clinical Trial — Completed
• Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation — Completed
• A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Participants With Chronic Heart Failure With Reduced Ejection Fraction — Completed
• Avoiding Treatment in the Hospital With Furoscix for the Management of Congestion in Heart Failure - A Pilot Study — Completed
• Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix) — Completed
• Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure — Completed
• A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) — Completed
• Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management — Completed
• Atrial Fibrillation Associated With Heart Failure Treated by BIOTRONIK's CRT-DX System — Stopped early
• The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) — Stopped early
• QP ExCELs: MultiPole Pacing (MPP) Sub-Study — Completed
• Model 4396 Left Ventricular (LV) Lead Chronic Performance Study — Completed
• Personalized CRT - MPP Post Approval Study — Completed
• Plexa ICD Lead Registry — Stopped early
• Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal Arteries — Completed
• LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB) — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• Ranolazine Implantable Cardioverter-Defibrillator Trial — Completed
• Micra Transcatheter Pacing System Continued Access Study Protocol — Completed
• Micra Transcatheter Pacing Study — Completed
• A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery — Completed
• ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial — Stopped early
• A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT) — Completed
• EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan — Completed
• A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels. — Completed